Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 14 February 2024
Accepted: 3 May 2024
First Online: 13 May 2024
Declarations
:
: ML served as speaker for Shionogi and consultant for AOP Pharma and Viatris. NDN serves on advisory boards for Inotrem and Adrenomed. LR has no conflict of interest to disclose.
